[1. Maseri A. Ischemic Heart Disease, New York, Churchill Livingstone. 1995; 713.]Search in Google Scholar
[2. World Health Organization; Atlas of Heart Disease and Stroke. Deaths from Coronary Heart Disease. [2011].]Search in Google Scholar
[3. Strong K, et al. Preventing chronic diseases: how many lives can we save? Lancet. 2005; 366(9496): p. 1578-82.]Search in Google Scholar
[4. Gaziano TA, et al., Growing epidemic of coronary heart disease in low and middle-income countries. Curr Probl Cardiol. 2010; 35(2): p. 72-115.10.1016/j.cpcardiol.2009.10.002]Search in Google Scholar
[5. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992; 326: 242.10.1056/NEJM199201233260406]Search in Google Scholar
[6. Ross R, Fuster V. The patogenesis of atherosclerosis. In Fuster V, Ross R, Topol EJ (eds). Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippincott- Raven. 1996; 441-462.]Search in Google Scholar
[7. De Vreede JJM, Gorgels APM, Verstraaten GMP, et al. Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol. 1991; 18: 698.10.1016/0735-1097(91)90792-8]Search in Google Scholar
[8. Rentrop KP. Restoration of anterograde flow in acute myocardial infarction: The first 15 years. J Am Coll Cardiol. 1995; 25: 1S.10.1016/0735-1097(95)00143-R]Search in Google Scholar
[9. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351): 13-20.10.1016/S0140-6736(03)12113-7]Search in Google Scholar
[10. Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2011; 32(15): 1854-1864 (Epub 2011 Jun 29).]Search in Google Scholar
[11. Elbarouni B, Elmanfuld O, Yan RT, et al. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Am Heart J. 2010; 160(3): 420-427.10.1016/j.ahj.2010.05.03620826248]Search in Google Scholar
[12. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011; 364: 226-235.10.1056/NEJMoa100235821247313]Search in Google Scholar
[13. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362: 2155-2165.10.1056/NEJMoa090861020558366]Search in Google Scholar
[14. Fox KA, Eagle KA, Gore JM, et al. The Global Registry of Acute Coronary Events, 1999 to 2009 - GRACE. Heart. 2010; 96: 1095-1101.10.1136/hrt.2009.19082720511625]Search in Google Scholar
[15. Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999; 281: 707-713.10.1001/jama.281.8.70710052440]Search in Google Scholar
[16. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006; 27: 2285-2293.10.1093/eurheartj/ehl196]Search in Google Scholar
[17. Dubois C, Pierard LA, Smeets JP, et al. Short and long term prognostic importance of complete bundle branch complicating acute myocardial infarction. Clin Cardiol. 1988; 11: 292.10.1002/clc.4960110504]Search in Google Scholar
[18. Bjerregaard P, Gussak I, Kotar SL, et al. Recurrent syncope in a patient with prominent J wave. Am Heart J. 1994; 127: 1426.10.1016/0002-8703(94)90070-1]Search in Google Scholar
[19. Braunwald E. The open-artery theory is alive and well - again. N Engl J Med. 1993; 329: 1650.10.1056/NEJM199311253292211]Search in Google Scholar
[20. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. Am Coll Cardiol. 1992; 20: 1391.10.1016/0735-1097(92)90253-J]Search in Google Scholar
[21. Cannon A, Freedman SB, Bailey BP, et al. ST-segment changes during transmural myocardial ischemia in chronic left bundle branch block. Am J Cardiol. 1989; 64: 1216.10.1016/0002-9149(89)90886-2]Search in Google Scholar
[22. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndrome. Am J Cardiol. 1989; 63: 114E.10.1016/0002-9149(89)90242-7]Search in Google Scholar
[23. Fallon JT. Pathology of myocardial infarction and reperfusion. In Fuster V, Ross R, and Topol EJ (eds). Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippincott-Raven. 1996; 791-796.]Search in Google Scholar
[24. Fesmire FM. ECG diagnosis of acute myocardial infarction in the presence of left bundle-branch block in patients undergoing continuous ECG monitoring. Ann Emerg Med. 1995; 26: 69-82.10.1016/S0196-0644(95)70241-5]Search in Google Scholar
[25. Flowers NC. Left bundle branch block: A continuously evolving concept. J Am Coll Cardiol. 1987; 9: 684.10.1016/S0735-1097(87)80065-7]Search in Google Scholar
[26. Forrester JS, Wyatt HL, Daluz, PL, et al. Functional significance of regional ischaemic contraction abnormalities. Circulation. 1976; 54: 64.10.1161/01.CIR.54.1.64]Search in Google Scholar
[27. Hands ME, Cook EF, Stone PH, et al. Electrocardiographic diagnosis of myocardial infarction in the presence of complete bundle branch block. Am Heart J. 1988; 116: 23.10.1016/0002-8703(88)90245-1]Search in Google Scholar
[28. Lamas GA, Mueller JE, Turi AG, et al. A simplified method to predict occurence of complete heart block during acute myocardial infarction. Am J Cardiol. 1986; 57: 1213.10.1016/0002-9149(86)90191-8]Search in Google Scholar
[29. Mullins CB, Atkins JM. Prognoses and management of ventricular conduction blocks in acute myocardial infarction. Mod Concepts Cardiovasc Dis. 1976; 45: 129.]Search in Google Scholar
[30. Oreto G, Saporito F, Donato G, et al. The "Inverse" R wave progression in inferior leads in the presence of left anterior hemiblock: A clinical study. J Electrocardiol. 1991; 24: 277.10.1016/0022-0736(91)90034-J]Search in Google Scholar
[31. Ricou F, Nicod P, Gilpin E, et al. Influence of right bundle branch block on short and long term survival after acute anterior myocardial infarction. J Am Coll Cardiol. 1991; 17: 858.10.1016/0735-1097(91)90865-7]Search in Google Scholar
[32. Rosenbaum MB, Girotti LA, Lazzari JO, et al. Abnormal Q waves in right sided chest leads provoked by onset of right bundle branch block in patients with antero-septal infarction. Br Heart J. 1982; 47: 227.10.1136/hrt.47.3.227]Search in Google Scholar
[33. Scheinman MM, Gonzales RP. Fascicular block and acute myocardial infarction. JAMA. 1980; 244: 2646.10.1001/jama.1980.03310230046027]Search in Google Scholar
[34. Schuster EH, Bulkley BH. Ischemia at a distance after acute myocardial infarction: A cause of early postinfarction angina. Circulation. 1980; 62: 509.10.1161/01.CIR.62.3.509]Search in Google Scholar
[35. Watt TBJr, Freud GE, Durrer D, et al. Left anterior arborization block combined with right bundle branch block in canine and primate hearts. An electrocardiographic study. Circ Res. 1968; 22: 57.10.1161/01.RES.22.1.57]Search in Google Scholar
[36. White HD, Norris RM, Brown MA, et al. Left ventricular end sistolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987; 76: 44.10.1161/01.CIR.76.1.44]Search in Google Scholar
[37. Willems JL, Robles de Medina E, Bernard R, et al. WHO task force on criteria for intraventricular conduction disturbances and pre-excitation. J Am Coll Cardiol. 1985; 5: 1261.10.1016/S0735-1097(85)80335-1]Search in Google Scholar
[38. Brilakis E, Wright S, Kopecky S, et al. Bundle branch block as a predictor of long-term survival after acute myocardial infarction. Am J Cardiol. 2001; 88: 205-209.10.1016/S0002-9149(01)01626-5]Search in Google Scholar
[39. Go AS, Barron HV, Rundle AC, et al. Bundle branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. Ann Intern Med. 1998; 129: 690-697.]Search in Google Scholar
[40. Serruys P. and Y. Onuma, 5-Year Cohort A and 2- Year Cohort B Results: Integrated Insights, in TCT 2011: San Francisco.]Search in Google Scholar
[41. Chevalier B. ABSORB Cohort B Trial: Evaluation of the ABSORB Bioresorbable Everolimus-Eluting Vascular Scaffold in the Treatment of Patients with de novo Native Coronary Artery Lesions. in American College of Cardiology. 2011. New Orleans.10.1016/S0735-1097(11)61642-2]Search in Google Scholar
[42. Dudek D. ABSORB Cohort B Trial: Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de novo Native Coronary Artery Lesions - 2-Year Clinical Results in American College of Cardiology. 2012. Chicago.10.1016/S0735-1097(12)60320-9]Search in Google Scholar
[43. Van Geuns, R.J. Preliminary data from ABSORB EXTEND: A report of the 6-month clinical outcomes from the first 269 patients registered, in EuroPCR Focus on BVS 2012, (presentation): Rotterdam, Netherlands.]Search in Google Scholar
[44. Onuma, Y. and P. Serruys. Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization? Circulation. 2011; 123: p. 779-797.10.1161/CIRCULATIONAHA.110.971606]Search in Google Scholar
[45. Koster R et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet, 2000. 356(9245): p. 1895-7.10.1016/S0140-6736(00)03262-1]Search in Google Scholar
[46. Diletti R, Farooq V, Girasis C, et al. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. Heart. 2013; 99: 98-105.10.1136/heartjnl-2012-30259823118346]Search in Google Scholar
[47. Muramatsu T, Onuma Y, Garcia-Garcia HM, et al. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORBEXTEND single-arm trial in comparison with an everolimus- eluting metallic stent in the SPIRIT first and II trials. JACC Cardiovasc Interv. 2013; 6: 247-257.10.1016/j.jcin.2012.10.01323517836]Search in Google Scholar
[48. Iqbal J, Onuma Y, Ormiston J et al. Bioresorbable coronary scaffolds: a novel device-based solution in search of its clinical need. Eur Heart J. 2014; 35: 753-757.10.1093/eurheartj/ehu00524553720]Search in Google Scholar
[49. Serruys PW, Onuma Y, Garcia-Garcia HM et al. Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention 2014; in press.10.4244/EIJV9I11A21724291783]Search in Google Scholar
[50. Dilleti R, Serruys PW, Farooq V, et al. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, afficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-elu ting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. Am Heart J. 2012; 164: 654-63.10.1016/j.ahj.2012.08.01023137495]Search in Google Scholar